Vimarsana
Biggest News Aggregation in the World

Finding Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Finding Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Finding Study Today - Breaking & Trending Today

Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation - Vimarsana News

Bayer Championing Advancements in Radiology Pipeline and Accelerating AI Innovation

Comprehensive program focused on innovation in AI – hosted jointly by teams from Calantic Digital Solutions and Blackford Analysis 

More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting - Vimarsana News

More than 50 Abstracts from Incyte's Robust Oncology Portfolio to be Featured at the 64th ASH Annual Meeting

- Plenary Scientific Session to highlight Incyte-discovered novel anti-mutant CALR-targeted monoclonal antibody INCA033989 - Data from three of the Company's LIMBER studies evaluating ruxolitinib

Bracco Features its Mission of 'No Compromise in MRI' at the 2022 Radiological Society of North America Annual Congress - Vimarsana News

Bracco Features its Mission of 'No Compromise in MRI' at the 2022 Radiological Society of North America Annual Congress

Bracco's attendance at RSNA follows FDA approval of Gadopiclenol injection, a novel macrocyclic high-relaxivity gadolinium-based contrast agent wh...

Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent - Vimarsana News

Bracco and Guerbet Partner to Expand Access to Novel Imaging Agent

Bracco Diagnostics Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved Gadopiclenol Injection, a new, highly stable macrocyclic gadolinium-based contrast agent (GBCA). The introduction of VUEWAY injection is the result of a strategic, global collaboration between Bracco and Guerbet in both research, development, and manufacturing of the product signed in December 2021.